All change at Galen as profits double

Pharmaceutical company Galen has seen pre-tax profits double to $48m (€40.38m) in Q2 and directors are to recommend a name change to shareholders at year's end to Warner Chilcott PLC.

All change at Galen as profits double

Pharmaceutical company Galen has seen pre-tax profits double to $48m (€40.38m) in Q2 and directors are to recommend a name change to shareholders at year's end to Warner Chilcott PLC.

This reflects the Craigavon-based firm's now exclusive focus on the US market following the sale of its non-core businesses in the UK.

Already a subscriber? Sign in

You have reached your article limit.

Subscribe to access all of the Irish Examiner.

Annual €130 €80

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited